Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies.

Vanhee M, Van Breedam W, Costers S, Geldhof M, Noppe Y, Nauwynck H.

Vaccine. 2011 Jun 24;29(29-30):4794-804. doi: 10.1016/j.vaccine.2011.04.071. Epub 2011 May 7.

2.

GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.

Costers S, Vanhee M, Van Breedam W, Van Doorsselaere J, Geldhof M, Nauwynck HJ.

Virus Res. 2010 Dec;154(1-2):104-13. doi: 10.1016/j.virusres.2010.08.026. Epub 2010 Sep 15. Review.

PMID:
20837070
3.
4.
5.
6.

Porcine reproductive and respiratory syndrome virus (PRRSV)-specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virus.

Van Breedam W, Costers S, Vanhee M, Gagnon CA, Rodríguez-Gómez IM, Geldhof M, Verbeeck M, Van Doorsselaere J, Karniychuk U, Nauwynck HJ.

Vet Immunol Immunopathol. 2011 Jun 15;141(3-4):246-57. doi: 10.1016/j.vetimm.2011.03.008. Epub 2011 Mar 12.

PMID:
21470695
7.
8.
9.

CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.

Cao J, Wang X, Du Y, Li Y, Wang X, Jiang P.

Vaccine. 2010 Nov 3;28(47):7514-22. doi: 10.1016/j.vaccine.2010.09.002. Epub 2010 Sep 17.

PMID:
20851084
10.
11.

Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.

Piñeyro PE, Kenney SP, Giménez-Lirola LG, Heffron CL, Matzinger SR, Opriessnig T, Meng XJ.

Virus Res. 2015 Dec 2;210:154-64. doi: 10.1016/j.virusres.2015.07.027. Epub 2015 Jul 31.

PMID:
26239318
12.

HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.

Li J, Jiang P, Li Y, Wang X, Cao J, Wang X, Zeshan B.

Vaccine. 2009 Feb 5;27(6):825-32. doi: 10.1016/j.vaccine.2008.11.088. Epub 2008 Dec 12.

PMID:
19070639
13.

Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus.

Jiang W, Jiang P, Wang X, Li Y, Du Y, Wang X.

Virus Res. 2008 Sep;136(1-2):50-7. doi: 10.1016/j.virusres.2008.04.016. Epub 2008 Jun 6.

PMID:
18538882
14.

Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.

Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ.

J Virol. 2002 May;76(9):4241-50. Erratum in: J Virol 2002 Jul;76(13):6863.

15.

Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response.

Das PB, Vu HL, Dinh PX, Cooney JL, Kwon B, Osorio FA, Pattnaik AK.

Virology. 2011 Feb 20;410(2):385-94. doi: 10.1016/j.virol.2010.12.002. Epub 2010 Dec 30.

16.

Antigenic structure analysis of glycosylated protein 3 of porcine reproductive and respiratory syndrome virus.

Zhou YJ, An TQ, He YX, Liu JX, Qiu HJ, Wang YF, Tong G.

Virus Res. 2006 Jun;118(1-2):98-104. Epub 2005 Dec 27.

PMID:
16384621
17.

A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains.

Vanhee M, Costers S, Van Breedam W, Geldhof MF, Van Doorsselaere J, Nauwynck HJ.

Viral Immunol. 2010 Aug;23(4):403-13. doi: 10.1089/vim.2010.0025.

18.

Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes.

Li J, Murtaugh MP.

Virology. 2012 Nov 25;433(2):367-76. doi: 10.1016/j.virol.2012.08.026. Epub 2012 Sep 12.

20.

GP4 of porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to immunoselection in vitro.

Costers S, Lefebvre DJ, Van Doorsselaere J, Vanhee M, Delputte PL, Nauwynck HJ.

Arch Virol. 2010 Mar;155(3):371-8. doi: 10.1007/s00705-009-0582-7. Epub 2010 Jan 7.

PMID:
20052599
Items per page

Supplemental Content

Write to the Help Desk